Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis

American Journal of Reproductive Immunology

Volumn 60, Issue 5, 2008, Pages 426-431

  Coulam, Carolyn B ^a,b,f   Wallis, Diane ^c   Weinstein, Jordan ^c   Dasgupta, Dipankar S ^d   Jeyendran, Rajasingam S ^e  

^a Rinehart Center for Reproductive Medicine   (United States)

^b Millenova Immunology Laboratories   (United States)

^c Midwest Heart Specialists   (United States)

^d Chicago Lake Shore Medical Associates Ltd   (United States)

^e Andrology Laboratory Services   (United States)

^f NONE   (United States)

Author keywords

Deep vein thrombosis; Inherited thrombophilia; Recurrent pregnancy loss; Thrombophilic genes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARGININE; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; FIBRINOGEN; GLUTAMINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBOCYTE ANTIGEN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DNA DETERMINATION; FEMALE; FEMALE FERTILITY; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; ORAL BIOPSY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RECURRENT ABORTION; RISK FACTOR; THROMBOPHILIA;

ABORTION, HABITUAL; BLOOD COAGULATION FACTORS; FEMALE; HUMANS; MALE; MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 54049097572     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00640.x     Document Type: Article

References (26)

1. Regan L, Rai R: Thrombophilia and pregnancy loss. J Reprod Immunol 2002; 55: 163-180.
2. Hiller E, Pihusch R: Thrombophilia caused by congenital disorders of blood coagulation. Semin Thromb Hemost 1998; 116: 26-32.
3. Sykes TCF, Fegan C, Mosquera D: Thrombophilia, polymorphisms and vascular disease. J Clin Path 2000; 53: 300-306.
4. Sartori MT, Danesin C, Saggiorata G, Tormene D, Simioni P, Spiezia L, Pastrassi GM, Girolami A: The PAI-1 gene 4G/4G polymorphisms in deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost 2003; 9: 299-307.
5. Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, Hill JA: Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Int Med 1998; 128: 1000-1003.
6. Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben-Ami M: Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol 2000; 43: 31-35.
7. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY: Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 2002; 7: 300-305.
8. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, Zournatzi V, Makris PE, Bontis J, Kotsis A: Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000; 15: 458-462.
9. Reznikoff-Etievan MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J: Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. Br J Obstet Gynecol 2001; 108: 1251-1254.
10. Pihusch R, Buchholz T, Lohse P, Rubsamen H, Rogenhofer N, Hasbargen U, Hiller E, Thaler CJ: Thrombophilic gene mutations and recurrent spontaneous abortion: Prothrombin mutation increases the risk in the first trimester. Am Journal Reprod Immunol 2001; 46: 124-131.
11. Coulam CB, Jeyendran RS, Fishel LA, Roussev RG: Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 2006; 55: 360-368.
12. Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R: Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol 2006; 56: 230-236.
13. Kutteh WH, Park VM, Deitcher SR: Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999; 71: 1048-1053.
14. Dizon-Townson DS, Kinney S, Branch DW, Ward K: The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol 1997; 34: 217-223.
15. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou JP, Scarabin PY, Bara L, Green F, Cambien F: Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation 1996; 93: 440-449.
16. Kohler HP, Futers TS, Grant PJ: Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Association with FXIII activity and antigen levels. Thromb Haemost 1999; 81: 511-515.
17. Eriksson P, Kallin B, van Hooft FM, Bavenholm P, Hamsten A: Allele-specific increase in basal transcription of the plasminogen-activator 1 gene is associated with myocardial infarction. PNAS 1995; 92: 1851-1855.
18. Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG: Platelet glycoprotein IIb/IIIa homozygosity associated with risk of ischemic cardiovascular diseases and myocardial infarction in young men: the Copenhagen City Heart Study. J Am Coll Cardiol 2003; 42: 661-667.
19. Miloszewski K, Losowsky M: Fibrin stabilisation and factor XIII deficiency. In Fibrinogen, Fibrin Stabilisation and Fibrinolysis, L Francis (ed). Chichester, UK, Ellis Horwood, 1988, p 175.
20. Aflalo ED, Sod-Moriah UA, Potashnik G, Har-Vardi I: Differences in the implantation rates of rat embryos developed in vivo and in vitro: possible role for plasminogen activators. Fertil Steril 2004; 81 (Suppl 1): 780-785.
21. Chung HW, Wen Y, Ahn JJ, Moon HS, Polan ML: Interleukin-1 beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells. J Clin Endocrinol Metab 2001; 86: 1332-1340.
22. Gluek CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T: The 4G/5G of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: An independent risk factor for serious pregnancy complications. Metabolism 2000; 49: 845-852.
23. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hedon B, Maros P: Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians Haematologists (NOHA) study. Thromb Haemost 1997; 77: 1096-1103.
24. Greer IA: The challenge of thrombophilia in maternal-fetal medicine. N Engl J Med 2000; 342: 424-425.
25. Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli X, Girolami A, Bernardi F: Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood 2000; 96: 1443-1448.
26. Kluijtmans LA, van den Heuvel LP, Boers GH, Frost P, Stevens EM, van Oost BA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ: Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 55: 35-41.